Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease Trial Phase 1 Completed Oct. 1, 2015
Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease - Evolution Trial N/A Completed Sept. 29, 2015
Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease Trial Phase 2 Unknown Sept. 28, 2015
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon Trial Phase 3 Completed Sept. 17, 2015
Efficacy of Acupuncture and Bee Venom Acupuncture on Patients With Idiopathic Parkinson's Disease Trial N/A Completed Sept. 8, 2015
Assessment of Social-emotional Functioning in Neurological Diseases Trial N/A Completed Sept. 6, 2015
Treatment of Orthostatic Intolerance in Patients With Parkinson's Disease Using Midodrine Trial N/A Unknown Aug. 25, 2015
Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone Trial Phase 1 Completed Aug. 20, 2015
An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites Trial Phase 1 Completed Aug. 20, 2015
Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic Trial Phase 1 Completed Aug. 19, 2015
Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease Trial Phase 1 Completed Aug. 16, 2015
Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa Trial Phase 1 Completed Aug. 16, 2015